» Articles » PMID: 38737586

Exploration of the Causal Associations Between Circulating Inflammatory Proteins, Immune Cells, and Neuromyelitis Optica Spectrum Disorder: a Bidirectional Mendelian Randomization Study and Mediation Analysis

Overview
Specialty Geriatrics
Date 2024 May 13
PMID 38737586
Authors
Affiliations
Soon will be listed here.
Abstract

Background: An increasing body of research has demonstrated a robust correlation between circulating inflammatory proteins and neuromyelitis optica spectrum disorders (NMOSD). However, whether this association is causal or whether immune cells act as mediators currently remains unclear.

Methods: We employed bidirectional two-sample Mendelian randomization (TSMR) analysis to examine the potential causal association between circulating inflammatory proteins, immune cells, and NMOSD using data from genome-wide association studies (GWAS). Five different methods for Mendelian randomization analyses were applied, with the inverse variance-weighted (IVW) method being the primary approach. Sensitivity analyses were further performed to assess the presence of horizontal pleiotropy and heterogeneity in the results. Finally, a two-step Mendelian randomization (MR) design was employed to examine the potential mediating effects of immune cells.

Results: A notable causal relationship was observed between three circulating inflammatory proteins (CSF-1, IL-24, and TNFRSF9) and genetically predicted NMOSD. Furthermore, two immune cell phenotypes, genetically predicted CD8 on naive CD8+ T cells, and Hematopoietic Stem Cell Absolute Count were negatively and positively associated with genetically predicted NMOSD, respectively, although they did not appear to function as mediators.

Conclusion: Circulating inflammatory proteins and immune cells are causally associated with NMOSD. Immune cells do not appear to mediate the pathway linking circulating inflammatory proteins to NMOSD.

References
1.
Hagan N, Kane J, Grover D, Woodworth L, Madore C, Saleh J . CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death Dis. 2020; 11(10):904. PMC: 7584629. DOI: 10.1038/s41419-020-03084-7. View

2.
Burt R, Balabanov R, Han X, Burns C, Gastala J, Jovanovic B . Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica. Neurology. 2019; 93(18):e1732-e1741. PMC: 6946475. DOI: 10.1212/WNL.0000000000008394. View

3.
Orru V, Steri M, Sidore C, Marongiu M, Serra V, Olla S . Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020; 52(10):1036-1045. PMC: 8517961. DOI: 10.1038/s41588-020-0684-4. View

4.
Vincent T, Saikali P, Cayrol R, Roth A, Bar-Or A, Prat A . Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol. 2008; 181(8):5730-7. DOI: 10.4049/jimmunol.181.8.5730. View

5.
Carnero Contentti E, Correale J . Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflammation. 2021; 18(1):208. PMC: 8444436. DOI: 10.1186/s12974-021-02249-1. View